[1]
R. Moody, “The effect of double-carbapenem therapy on mortality rates and microbiological cure rates in patients diagnosed with carbapenem-resistant Klebsiella pneumoniae infections in comparison to monotherapy and currently used combinations of antibiotics”, J Med Res Innov, vol. 5, no. 1, p. e000243, Jan. 2021.